Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
Jan 03, 2012 Nature speaks with Keim about H5N1 studies -
-
-
Jun 20, 2011 Promising skin-cancer drug nears approval
Share on Twitter
Share on Facebook
Email to a friend
Print Article
New international study targets rare cancer bringing hope for advanced thymic cancer patients
[Source: TGen] - The Translational Genomics Research Institute (TGen) and Scottsdale Healthcare are testing a new drug specifically for thymic cancer based on early promising results at Scottsdale Healthcare.
PHA-848125AC is produced by Nerviano Medical Sciences of Milan, Italy’s largest pharmaceutical research and development facility. It is designed to stop abnormal cell division and duplication, a common feature of cancer.
For more information: New international study targets rare cancer bringing hope for advanced thymic cancer patients
Quick Links
- NEW: About the Arizona Center for Civic Leadership
- Arizona Biosciences News
- Arizona BioMap
- Roadmap Progress Updates
- Reports & Multimedia
- Timeline: Arizona's Bio Growth
- Arizona Bio Orgs on Twitter
- Arizona BioBasics
- The Biozona Brand
- Newsletter Signup
Download a new brochure from the Flinn Foundation outlining the 2011 progress on Arizona's Bioscienced Roadmap: a record high in bioscience jobs, plus gains in firms and venture-capital funding. Numerous achievements during the year advanced the core strategies of the Roadmap.
Also, read the full Performance Assessment describing in detail Arizona's 2011 progress on key Roadmap metrics.
